Department of Emergency Medicine, Mayo Clinic, Rochester, Minn.
Department of Emergency Medicine, Mayo Clinic, Rochester, Minn.
J Allergy Clin Immunol Pract. 2015 Jul-Aug;3(4):576-84. doi: 10.1016/j.jaip.2015.04.009. Epub 2015 May 29.
Risk factors that predict which patients with anaphylaxis might require repeat doses of epinephrine are poorly understood.
The objective of this study was to identify risk factors associated with the need for multiple doses of epinephrine during an anaphylactic reaction.
Patients were included if they met diagnostic criteria for anaphylaxis on presentation to the emergency department (ED) at our academic medical center between April 2008 and February 2014. Data were collected on allergic history, presenting signs and symptoms, anaphylaxis management, and disposition. Univariable and multivariable analyses were performed to estimate associations between possible risk factors and the need for multiple doses.
Of 582 ED patients with anaphylaxis, 45 (8%) required multiple doses of epinephrine. By multivariable analysis, factors associated with the need for repeat doses were a history of anaphylaxis (odds ratio [OR], 2.5 [95% CI, 1.3-4.7]; P = .005), the presence of flushing or diaphoresis (OR, 2.4 [95% CI, 1.3-4.5]; P = .007), and the presence of dyspnea (OR, 2.2 [95% CI, 1.0-5.0]; P = .046). Patients who received more than 1 dose were more likely to be admitted to the general medical floor (OR, 2.8 [95% CI, 1.1-7.2]; P = .03) or intensive care unit (OR, 7.6 [95% CI, 3.7-15.6]; P < .001).
Patients with a history of anaphylaxis, flushing or diaphoresis, or dyspnea may require multiple doses of epinephrine to treat anaphylactic reactions. Patients who require more than 1 dose are more likely to be admitted to the hospital, thus increasing health care resource utilization.
预测哪些过敏反应患者可能需要重复使用肾上腺素的风险因素尚未得到很好的理解。
本研究的目的是确定与过敏反应期间需要多次使用肾上腺素相关的风险因素。
如果患者在 2008 年 4 月至 2014 年 2 月期间在我们的学术医疗中心的急诊部就诊时符合过敏反应的诊断标准,则将其纳入研究。收集过敏史、就诊时的症状和体征、过敏反应的管理以及转归等数据。进行单变量和多变量分析,以评估可能的风险因素与需要多次使用肾上腺素之间的关联。
在 582 例过敏反应的 ED 患者中,有 45 例(8%)需要多次使用肾上腺素。通过多变量分析,与需要重复剂量相关的因素是过敏反应史(比值比[OR],2.5[95%CI,1.3-4.7];P=.005)、潮红或出汗(OR,2.4[95%CI,1.3-4.5];P=.007)和呼吸困难(OR,2.2[95%CI,1.0-5.0];P=.046)。接受超过 1 剂的患者更有可能被收治到普通医疗病房(OR,2.8[95%CI,1.1-7.2];P=.03)或重症监护病房(OR,7.6[95%CI,3.7-15.6];P<.001)。
有过敏反应史、潮红或出汗或呼吸困难的患者可能需要多次使用肾上腺素来治疗过敏反应。需要超过 1 剂的患者更有可能住院,从而增加医疗资源的利用。